1207.HK $0.01 0%
MIGO.L $324.00 0.6211%
IIM $11.75 -0.4592%
EVRI $14.43 -1.1309%
0NDP.L $5.46 1.2811%
MLSDN.PA $30.00 0%
KAL $1.12 0%
2297.HK $1.09 0%
0943.HK $0.01 0%
PRFX $0.61 -0.1976%
CHRS $4.87 -6.262%
MESA $1.51 6.338%
EOG $109.84 -0.6243%
0297.HK $1.07 -4.4643%
BLTE $26.45 -2.0007%
TDS-PV $10.07 -2.7053%
EOSE $2.44 12.212%
ACAB $10.32 0.097%
KNDI $3.25 -0.1538%
RISR $31.78 -0.4074%
CRZNW $0.00 0%
MQT $10.06 -0.0497%
ASHS $31.18 -1.5307%
OII $16.11 -0.3711%
1351.HK $0.36 1.4085%
PSMT $70.84 -0.5894%
RKLY $0.19 0%
AFME.PA $1.40 -0.7092%
AASI.PA $30.93 -0.347%
2358.HK $0.09 -5.26316%
3958.HK $4.74 -1.4553%
0HYB.L $98.99 0%
SPSM $35.64 -0.8899%
0KF5.L $197.73 0.4923%
RMI $16.51 -1.3034%
HPP $4.35 -5.4348%
FRW $10.02 0%
CTEX $30.81 1.0436%
SCIN $13.78 0%
AALR3.SA $22.70 -0.088%
0KRX.L $78.32 -1.8436%
EXTR $16.56 -0.361%
CLA.PA $1.99 -6.5728%
MSTR $276.38 -3.8234%
SHCR $1.46 -1.0204%
HUBB $272.80 0.0183%
0HI1.L $118.70 0.0147%
TOK $88.00 -0.1108%
PSYK $16.48 0%
SABR $3.18 -6.4706%
2159.HK $0.98 1.0309%
E127.L $34.75 0%
MTEK $0.95 -2.3897%
GKOS $59.07 0.2886%
CKX $9.81 1.9221%
MDU $29.04 -0.5651%
OBI.L $17.79 -3.8649%
TMHC $43.27 -1.5472%
OCAXW $0.05 -2.3593%
ETN $167.06 -0.8664%
GSIT $3.80 131.665%
NXST $158.37 0.7571%
INL.L $8.50 0%
GVIP $76.47 -0.8371%
MGLD $1.56 0%
ESQ $40.05 1.7143%
EEEL3.SA $421.01 0%
MFEM $18.06 -0.9836%
0430.HK $0.38 1.3333%
CBE.PA $782.10 0%
OCN $27.60 -0.6122%
MAV4.L $63.00 0%
EO.PA $18.47 3.1555%
EEMD $17.65 -1.8329%
VARE.L $45.15 -2.9032%
0432.HK $0.33 0%
SENT $22.11 -0.8827%
AIVL $89.79 -0.4544%
PHG.PA $149.11 0.1733%
PPI $24.33 -0.2721%
PUAL.L $122.50 0%
PWFL $2.90 -0.6849%
TETC $10.18 0%
PBFX $19.90 0%
RAT.L $1 914.00 -0.4162%
0HC7.L $196.03 -1.3674%
0310.HK $0.02 0%
QTEC $123.50 -0.5876%
NOACU $10.04 0%
DBDRU $0.00 0%
NBS.L $118.25 0.2119%
NRIM $35.15 1.0058%
CRM $201.05 -1.1894%
RZB $24.44 0.7005%
1270.HK $1.03 0%
0011.HK $113.40 -0.439%
XMUD.L $119.09 0.4259%
NA $1.08 0%
ARKF $18.22 -2.9051%
Eng
Логотип
Eng
Лого

Eucrates Biomedical Acquisition Corp. EUCR

$10.04

На 18:04, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    42228842.00000000

  • week52high

    10.25

  • week52low

    9.87

  • Revenue

    0

  • P/E TTM

    16

  • Beta

    -0.07423900

  • EPS

    0.21000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    31 мар 2021 г. в 10:59

Описание компании

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек